Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The NADage Study: a Randomized Double-blind Trial of NAD Replenishment Therapy on Aging

NCT06208527 is registered in ClinicalTrials.gov with Haukeland University Hospital as lead sponsor.

NCT NCT06208527
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06208527 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The NADage Study: a Randomized Double-blind Trial of NAD Replenishment Therapy on Aging
Lead sponsor
Haukeland University Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
January 31, 2025
Completion date
December 31, 2030
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

aging, frail elderly syndrome, frailty, frailty syndrome